Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Osteoporosis, Postmenopausal
Open-data reference.
13 US clinical trials · 2 currently recruiting
Active & Recent Trials
Combined Anabolic Therapy
Massachusetts General Hospital
NCT06558188
Mechanisms of Anabolic Osteoporosis Therapy
Massachusetts General Hospital
NCT05688969
Comparative Efficacy, Safety, PK, and Immunogenicity Study
Luye Pharma Group
NCT05853354
Romosozumab Use to Build Skeletal Integrity
Susan L. Greenspan
NCT05058976
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Hospital for Special Surgery, New York
NCT04467983
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Massachusetts General Hospital
NCT03623633
Patient- and Physician-Based Osteoporosis Education
Brigham and Women's Hospital
NCT00073190
Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Eli Lilly and Company
NCT00670501
Circulating miRNA in Primary Hyperparathyroidism
University of Pennsylvania
NCT03931109
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
University of Pittsburgh
NCT00222872
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
Eli Lilly and Company
NCT00557310
Effects of Black Cohosh on Menopausal Hot Flashes
National Center for Complementary and Integrative Health (NCCIH)
NCT00010712
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Eli Lilly and Company
NCT00046137
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 3 |
| Phase 4 | 5 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Osteoporosis, Postmenopausal Trial Landscape
ClinicalTrials.gov lists 13 US studies indexed under Osteoporosis, Postmenopausal, and 2 of those are currently open to recruitment — roughly 15% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Osteoporosis, Postmenopausal shows 8 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Osteoporosis, Postmenopausal is led by Eli Lilly and Company with 3 indexed trials, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Osteoporosis, Postmenopausal?
PlainTrial tracks 13 US clinical trials for Osteoporosis, Postmenopausal, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Osteoporosis, Postmenopausal?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.